Similar companies
Company | Revenue | |
---|---|---|
No data for previous quarter available yet. |
Income Statement (USD)
Q2 '24 | QoQ | |
---|---|---|
Revenue | 9.7B | 22.8% |
Gross Profit | 2.98B | 51% |
Cost of Revenue | 6.73B | 13.4% |
Operating expense | 4.38B | 14.1% |
Net Income | 654M | 50.5% |
EBITDA | 1.45B | 29.9% |
Balance Sheet (USD)
Q2 '24 | QoQ | |
---|---|---|
Total Assets | 90B | 0.9% |
Total Liabilities | 39.6B | 1.9% |
Total Equity | 50.2B | 3% |
Shares Outstanding | 1.31B | 1.4% |
Cash Flow (USD)
Q2 '24 | QoQ | |
---|---|---|
Cash from operations | 2.78B | 12.2% |
Cash from investing | -696M | 1.6% |
Cash from financing | -2.36B | 57.3% |
EPS
Financial Highlights for Medtronic in Q2 '24
Medtronic reported a revenue of 9.7B, which is a 22.8% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 2.98B, marking a 51% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 6.73B, a 13.4% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 4.38B, showing a 14.1% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 654M, showing a -50.5% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 1.45B, showing a -29.9% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Medtronic faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.